Skip Nav Destination
            
    
            
 
    
    
        
            
                
                    
                        
                        
                            
                        
                    
                
                    
                    
                        
                    
                
                
                    
                        
                        
                            
                        
                    
            
        
    
    
    
        
        
        
    
        
        
    
        
 
    
 
    
        
    
    
        
            
        
        
    
        
    
    
    
 
    
                
                    
            
    
        
    
    
                    
        
        
     
    
                     
    
                     
    
                    
                    
        
        Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                    
                    
                
            
    
    
    
        
        
     
    
                    
                    
                
            
    
    
    
                    
                
            
    
    
    
                    
        
        A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                     
    
                     
    
                     
    
                    
                    
                
            
    
    
    
        
        
     
    
                     
    
                    
                    
                
            
    
    
    
        
        
     
    
 
    
            
    
        
    
         
 
    
    
        
    
            
    
        
    
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
        
    
    
    
            
        
 
    
    
 
    
    
         
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
 
    
    
    
    
        
    Issue Archive
December 11 2014
    
    In this Issue
    
    Table of Contents
INSIDE BLOOD COMMENTARIES
PLENARY PAPER
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
        
        Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            David Garcia,John H. Alexander,Lars Wallentin,Daniel M. Wojdyla,Laine Thomas,Michael Hanna,Sana M. Al-Khatib,Paul Dorian,Jack Ansell,Patrick Commerford,Greg Flaker,Fernando Lanas,Dragos Vinereanu,Denis Xavier,Elaine M. Hylek,Claes Held,Freek W. A. Verheugt,Christopher B. Granger,Renato D. Lopes
            
        
    
            HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages
            Sietse Q. Nagelkerke,Gillian Dekkers,Iwan Kustiawan,Fleur S. van de Bovenkamp,Judy Geissler,Rosina Plomp,Manfred Wuhrer,Gestur Vidarsson,Theo Rispens,Timo K. van den Berg,Taco W. Kuijpers
            
        
    
            LYMPHOID NEOPLASIA
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
            Sofie Peirs,Filip Matthijssens,Steven Goossens,Inge Van de Walle,Katia Ruggero,Charles E. de Bock,Sandrine Degryse,Kirsten Canté-Barrett,Delphine Briot,Emmanuelle Clappier,Tim Lammens,Barbara De Moerloose,Yves Benoit,Bruce Poppe,Jules P. Meijerink,Jan Cools,Jean Soulier,Terence H. Rabbitts,Tom Taghon,Frank Speleman,Pieter Van Vlierberghe
            
        
    
            Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase
            James J. Steinhardt,Raymond J. Peroutka,Krystyna Mazan-Mamczarz,Qing Chen,Simone Houng,Carol Robles,Rolf N. Barth,Joseph DuBose,Brandon Bruns,Ronald Tesoriero,Deborah Stein,Raymond Fang,Nader Hanna,Jason Pasley,Carlos Rodriguez,Mark D. Kligman,Matthew Bradley,Joseph Rabin,Stacy Shackelford,Bojie Dai,Ari L. Landon,Thomas Scalea,Ferenc Livak,Ronald B. Gartenhaus
            
        
    
            
        
        A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
        
        
            
        
                    
                        Brief Report
                    
        
            
    
        
            Thirunavukkarasu Velusamy,Mark J. Kiel,Anagh A. Sahasrabuddhe,Delphine Rolland,Catherine A. Dixon,Nathanael G. Bailey,Bryan L. Betz,Noah A. Brown,Alexandra C. Hristov,Ryan A. Wilcox,Roberto N. Miranda,L. Jeffrey Medeiros,Yoon K. Jeon,Kedar V. Inamdar,Megan S. Lim,Kojo S. J. Elenitoba-Johnson
            
        
    
            MYELOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
            Christopher G. Kanakry,Hua-Ling Tsai,Javier Bolaños-Meade,B. Douglas Smith,Ivana Gojo,Jennifer A. Kanakry,Yvette L. Kasamon,Douglas E. Gladstone,William Matsui,Ivan Borrello,Carol Ann Huff,Lode J. Swinnen,Jonathan D. Powell,Keith W. Pratz,Amy E. DeZern,Margaret M. Showel,Michael A. McDevitt,Robert A. Brodsky,Mark J. Levis,Richard F. Ambinder,Ephraim J. Fuchs,Gary L. Rosner,Richard J. Jones,Leo Luznik
            
        
    
            BLOOD WORK
CORRESPONDENCE
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance
            Rosella Famà,Riccardo Bomben,Silvia Rasi,Michele Dal Bo,Carmela Ciardullo,Sara Monti,Francesca Rossi,Tiziana D’Agaro,Antonella Zucchetto,Valter Gattei,Gianluca Gaidano,Davide Rossi
            
        
    
            - 
        
            Cover Image
        
        Cover Image![issue cover]()  Acute promyelocytic leukemia cells after retinoid X receptor excision. PML immunofluorescence reveals the PML/RARA-specific microspeckled pattern. See the article by Vitaliano-Prunier et al on page 3772. 
- PDF Icon Front MatterFront Matter
- PDF Icon Table of ContentsTable of Contents
- PDF Icon Back MatterBack Matter
- PDF Icon AdvertisingAdvertising
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
 
                    